David James Lennon
CIK: 0001995275
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Whitehawk Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (18 total)
- Sep 15, 2026WHWK
Whitehawk Therapeutics, Inc.
Award(A)DirectRestricted Stock Units
194K shares- - Sep 15, 2026WHWK
Whitehawk Therapeutics, Inc.
Award(A)DirectStock option (right to buy)
194K shares- - May 14, 2026WHWK
Whitehawk Therapeutics, Inc.
Award(A)Direct51K shares at avg. $3.92$200K - Apr 9, 2026WHWK
Whitehawk Therapeutics, Inc.
Sale(S)Direct14.5K shares at avg. $3.38$49K - Apr 8, 2026WHWK
Whitehawk Therapeutics, Inc.
Sale(S)Direct63.9K shares at avg. $3.40$217K - Apr 7, 2026WHWK
Whitehawk Therapeutics, Inc.
Sale(S)Direct94.1K shares at avg. $3.43$323K - Apr 6, 2026WHWK
Whitehawk Therapeutics, Inc.
Sale(S)Direct102.4K shares at avg. $3.51$359K - Apr 2, 2026WHWK
Whitehawk Therapeutics, Inc.
Sale(S)Direct26.9K shares at avg. $3.48$93K - Apr 1, 2026WHWK
Whitehawk Therapeutics, Inc.
Exercise(M)Direct775.8K shares- - Apr 1, 2026WHWK
Whitehawk Therapeutics, Inc.
Award(A)DirectStock Option (right to buy)
831.1K shares- - Mar 2, 2026WHWK
Whitehawk Therapeutics, Inc.
Sale(S)Direct5.1K shares at avg. $3.31$17K - Mar 1, 2026WHWK
Whitehawk Therapeutics, Inc.
Exercise(M)Direct16.3K shares- - Apr 1, 2025WHWK
Whitehawk Therapeutics, Inc.
Award(A)DirectRestricted Stock Units
775.8K shares- - Apr 1, 2025WHWK
Whitehawk Therapeutics, Inc.
Award(A)DirectStock Option (right to buy)
775.8K shares- - Mar 3, 2025AADI
Aadi Bioscience, Inc.
Sale(S)Direct5.7K shares at avg. $2.35$13K - Mar 1, 2025AADI
Aadi Bioscience, Inc.
Exercise(M)Direct16.3K shares- - Oct 3, 2024AADI
Aadi Bioscience, Inc.
Sale(S)Direct9.7K shares at avg. $1.94$19K - Oct 2, 2024AADI
Aadi Bioscience, Inc.
Exercise(M)Direct32.6K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 15, 2026 | WHWK Whitehawk Therapeutics, Inc. | Award(A) Restricted Stock Units | 193,957 | - | - | Direct |
| Sep 15, 2026 | WHWK Whitehawk Therapeutics, Inc. | Award(A) Stock option (right to buy) | 193,957 | - | - | Direct |
| May 14, 2026 | WHWK Whitehawk Therapeutics, Inc. | Award(A) | 51,021 | $3.92 | $200,002 | Direct |
| Apr 9, 2026 | WHWK Whitehawk Therapeutics, Inc. | Sale(S) | 14,500 | $3.38 | $49,010 | Direct |
| Apr 8, 2026 | WHWK Whitehawk Therapeutics, Inc. | Sale(S) | 63,945 | $3.40 | $217,413 | Direct |
| Apr 7, 2026 | WHWK Whitehawk Therapeutics, Inc. | Sale(S) | 94,087 | $3.43 | $322,718 | Direct |
| Apr 6, 2026 | WHWK Whitehawk Therapeutics, Inc. | Sale(S) | 102,395 | $3.51 | $359,406 | Direct |
| Apr 2, 2026 | WHWK Whitehawk Therapeutics, Inc. | Sale(S) | 26,858 | $3.48 | $93,466 | Direct |
| Apr 1, 2026 | WHWK Whitehawk Therapeutics, Inc. | Exercise(M) | 775,828 | - | $0 | Direct |
| Apr 1, 2026 | WHWK Whitehawk Therapeutics, Inc. | Award(A) Stock Option (right to buy) | 831,148 | - | - | Direct |
| Mar 2, 2026 | WHWK Whitehawk Therapeutics, Inc. | Sale(S) | 5,100 | $3.31 | $16,879 | Direct |
| Mar 1, 2026 | WHWK Whitehawk Therapeutics, Inc. | Exercise(M) | 16,250 | - | $0 | Direct |
| Apr 1, 2025 | WHWK Whitehawk Therapeutics, Inc. | Award(A) Restricted Stock Units | 775,828 | - | - | Direct |
| Apr 1, 2025 | WHWK Whitehawk Therapeutics, Inc. | Award(A) Stock Option (right to buy) | 775,828 | - | - | Direct |
| Mar 3, 2025 |  AADI Aadi Bioscience, Inc. | Sale(S) | 5,690 | $2.35 | $13,372 | Direct |
| Mar 1, 2025 | AADI Aadi Bioscience, Inc. | Exercise(M) | 16,250 | - | - | Direct |
| Oct 3, 2024 | AADI Aadi Bioscience, Inc. | Sale(S) | 9,689 | $1.94 | $18,797 | Direct |
| Oct 2, 2024 | AADI Aadi Bioscience, Inc. | Exercise(M) | 32,558 | - | $0 | Direct |
1-18 of 18 transactions
About Lennon David James
Lennon David James (SEC CIK 0001995275) files insider reports with the SEC as CHIEF EXECUTIVE OFFICER of Whitehawk Therapeutics, Inc. (WHWK).
Signal8 holds 10 ownership filings by Lennon David James, all Form 4s, filed between Oct 3, 2024 and Sep 18, 2026. Those filings report 18 transactions, from Oct 2, 2024 to Sep 15, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Lennon David James's filings is in MORRISTOWN, NJ.
Recent filings by Lennon David James
- Sep 15, 2026: Grants or awards of WHWK derivative securities (2 lines, Form 4, code A).
- May 14, 2026: Grant or award of WHWK shares (Form 4, code A).
- Apr 9, 2026: Open-market sale of WHWK shares (Form 4, code S).
- Apr 8, 2026: Open-market sale of WHWK shares (Form 4, code S).
- Apr 7, 2026: Open-market sale of WHWK shares (Form 4, code S).
Other insiders filing for Whitehawk Therapeutics, Inc. (WHWK)
- Giacobello Scott M., CHIEF FINANCIAL OFFICER
- BALL BRYAN
- Dornan David, Chief Scientific Officer
- Dugan Margaret, Chief Medical Officer
- Iyengar Vijay K, Director
- Dalal Anupam, Director